Cancer

Manulife brings Guardant Health’s Shield MCD cancer screening to Hong Kong, Philippines, and Singapore

March 17 2026

The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.

aswata-peak-re-launch-cancer-care-programme-for-indonesians

New Aswata-Peak Re product offers Indonesian cancer patients US treatment and travel cover

February 12 2026

The new plan offers Indonesian residents up to US$2m in annual cover and access to leading US cancer centres.

malaysian-re-cpic-and-kunpeng-to-collaborate-on-development-of-health-insurance-products

Malaysian Re partners with CPIC and Kunpeng on health insurance product development

April 19 2024

New MOU aims to develop new products for Malaysian market, with a particular emphasis on cancer treatment.

A nurse is talking to a patient in a hospital bed.

Income Insurance and Swiss Re react to Singapore's rising cancer costs with new insurance product

August 24 2023

'Complete Cancer Care' has been introduced amid rising cancer treatment costs in Singapore, which is set to exceed SG$2bn (US$1.48b) by 2030.

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →